Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2011

View Archived Issues

KAI Pharmaceuticals releases clinical data on KAI-4169

Bendamustine evaluated in anaplastic glioma

Promising preclinical data presented on GBR-401

Potential new biomarker for the diagnosis of giant cell arteritis

Plasma biomarker of small cell lung cancer identified

DNA polymerase eta levels predict oxaliplatin efficacy in esophageal cancer

Bafetinib as potential therapeutic for Parkinson's disease

Merck & Co. designs novel beta3-adrenoceptor agonists

New lysophospholipid S1P1 receptor modulators disclosed by Allergan

Phase III study of DiaPep277 in type 1 diabetes meets primary endpoint

Selecta Biosciences commences clinical trial of vaccine for smoking cessation

New steroidal lactones from M. crassissima disclosed by PharmaMar

Portola completes financing round

Pierre Fabre Medicament gains approval to market Joncia in Australia

Pfizer to acquire Excaliard Pharmaceuticals

Japanese researchers prepare novel Toll-like receptor antagonists

Compounds that modulate skeletal muscle contractility disclosed by Cytokinetics

Cara Therapeutics starts first clinical study of oral CR-845

Swissmedic approves Celgene's Revlimid

GLPG-0634 shows signs of efficacy and safety in phase II study

Trimel Pharmaceuticals provides update on CompleoTRT study

EMA committee recommends approval of new indication for Herceptin

Phase III study investigates CXA-201 and metronidazole for intra-abdominal infections

Celgene to discontinue study of treatment regimen for castration-resistant prostate cancer

Landmark study to evaluate regenerative stem cell strategy to treat MS

Milestone reached in PsychoGenics/Roche drug discovery collaboration

FDA accepts for review Regeneron's sBLA for Arcalyst

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...